Descriptions:
Leading Cancer experts seeking to solve the problem have found that up to 36% of cancer cell lines analysed were mistakenly identified. In hundreds of documented cases that undermine a broad range of research, cancer samples that were supposed to be one type of tumour have turned out to be something else, through careless laboratory handling, mislabelling or other errors.
cell line, cell line authentication, mycoplasma, YSTR testing